(1 - 10 von 11
)
Blueprint Medicines' AYVAKYT® (avapritinib) Receives ...Blueprint Medicines
ir.blueprintmedicines.com
— ... Georg Pirmin Meyer , M.D., Senior Vice President, International at Blueprint Medicines . "We believe that AYVAKYT has the potential to shift ...
Sind Männer durch die Gleichberechtigung verunsichert, Pirmin...
www.ellexx.com
10. März · Der zweifache Vater Pirmin Meyer war der erste Mann in der Firma, der nach der Geburt das Pensum reduzierte. Meyer hat den Verein «WE/MEN» mitgegründet, der sich für Gleichberechtigung einsetzt. Mit seinen Freunden redet er nicht nur über die neusten Anzüge, sondern auch über psychische Gesundheit.
Avapritinib, indicazioni estese alla mastocitosi sistemica indolenpharmastar.it
www.pharmastar.it
— ... Georg Pirmin Meyer, Senior Vice President, International di Blueprint Medicines. "Per la prima volta in Europa i pazienti affetti da ISM — ... Georg Pirmin Meyer, Senior Vice President, International di Blueprint Medicines. "Per la prima volta in Europa i pazienti affetti da ISM ...
Blueprint Medicines Announces European Commission ...RTTNews
www.rttnews.com
— Georg Pirmin Meyer, Senior Vice President, International at Blueprint Medicines, said: "For the first time in Europe ISM patients have an — Georg Pirmin Meyer, Senior Vice President, International at Blueprint Medicines, said: "For the first time in Europe ISM patients have an ...
Blueprint Medicines announces approval of AYVAKYT for ...News-Medical
www.news-medical.net
— Georg Pirmin Meyer, M.D., Senior Vice President, International at Blueprint Medicines. “Indolent systemic mastocytosis can be characterized — Georg Pirmin Meyer, M.D., Senior Vice President, International at Blueprint Medicines. “Indolent systemic mastocytosis can be characterized ...
Blueprint Medicines' AYVAKYT® (avapritinib) Receives ...Ariva
www.ariva.de
— ... Georg Pirmin Meyer, M.D., Senior Vice President, International at Blueprint Medicines. "For the first time in Europe ISM patients have an — ... Georg Pirmin Meyer, M.D., Senior Vice President, International at Blueprint Medicines. "For the first time in Europe ISM patients have an ...
EC approves Blueprint's Ayvakyt as first treatment for rare ...PMLiVE
pmlive.com
— Georg Pirmin Meyer, senior vice president, international at Blueprint Medicines, said the approval “represents an important step toward — Georg Pirmin Meyer, senior vice president, international at Blueprint Medicines, said the approval “represents an important step toward ...
European Commission Approves Avapritinib for Indolent ...Rare Disease Advisor
www.rarediseaseadvisor.com
— ... Georg Pirmin Meyer, MD, senior vice president, at Blueprint Medicines. The approval is based on data from the double-blind, placebo — ... Georg Pirmin Meyer, MD, senior vice president, at Blueprint Medicines. The approval is based on data from the double-blind, placebo ...
Ok dall'Europa ad Avapritinib di Blueprint MedicinesMilano Finanza
www.milanofinanza.it
— ... Georg Pirmin Meyer, M.D., senior vice president, International di Blueprint Medicines – Crediamo che avapritinib abbia il potenziale per — ... Georg Pirmin Meyer, M.D., senior vice president, International di Blueprint Medicines – Crediamo che avapritinib abbia il potenziale per ...
[단독] GIST 치료제 '아이바키트' 적응증 확대 성공헬스코리아뉴스
www.hkn24.com
— 게오르크 피르민 마이어(Georg Pirmin Meyer) 블루프린트 메디슨 수석 부회장은 이와 관련 “비만세포증 환자들에게 새로운 치료 옵션을 제공할 수 — 게오르크 피르민 마이어(Georg Pirmin Meyer) 블루프린트 메디슨 수석 부회장은 이와 관련 “비만세포증 환자들에게 새로운 치료 옵션을 제공할 수 ...
sortiert nach Relevanz / Datum